METHYL 3-METHYL-4-NITROISOXAZOLE-5-CARBOXYLATE, 95.0%, 5g

(2S,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)butanenitrile, 98%, 25g

tert-Butyl (2R,4R)-2-(hydroxymethyl)-4-(trifluoromethyl)pyrrolidine-1-carboxylate, 97%, 1g

1-Methyl-4-vinylbenzene (stabilised with TBC), 96.0%, 5g

Methyl trifluoroacetate, 99.0%, 25g

Triallyl 1,3,5-Benzenetricarboxylate>98.0%(T)5g

Vortioxetine hydrobromide, 97.0%, 25g

h-his(trt)-oh, 95.0%, 25g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinolin-1(2H)-one, 95.0%, 500mg

2'-Deoxy-2'-fluorocytidine hydrate, 95.0%, 1g

4-Fluoro-3-(fluorosulfonyl)benzoic acid, 98%, 1g

2-AMINO-2-(4-CHLORO-3-FLUOROPHENYL)ETHAN-1-OL, 95.0%, 100mg

(6-(Dimethylamino)-4-methylpyridin-3-yl)boronic acid, 98+%, 10g